11/13
09:01 am
imrx
Immuneering (NASDAQ:IMRX) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $20.00 price target on the stock.
Medium
Report
Immuneering (NASDAQ:IMRX) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $20.00 price target on the stock.
11/13
08:48 am
imrx
Rating for IMRX
Medium
Report
Rating for IMRX
10/31
08:06 am
imrx
Immuneering (NASDAQ:IMRX) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $15.00 price target on the stock.
Medium
Report
Immuneering (NASDAQ:IMRX) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $15.00 price target on the stock.
10/31
07:01 am
imrx
Rating for IMRX
Medium
Report
Rating for IMRX
10/31
06:42 am
imrx
Immuneering initiated with an Outperform at Leerink
Medium
Report
Immuneering initiated with an Outperform at Leerink
9/30
08:05 am
imrx
Immuneering (NASDAQ:IMRX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $11.00 price target on the stock.
Medium
Report
Immuneering (NASDAQ:IMRX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $11.00 price target on the stock.
9/26
07:35 am
imrx
Rating for IMRX
Low
Report
Rating for IMRX
9/25
09:55 am
imrx
Rating for IMRX
Medium
Report
Rating for IMRX
9/25
09:55 am
imrx
Rating for IMRX
Medium
Report
Rating for IMRX
9/15
06:47 am
imrx
Rating for IMRX
Medium
Report
Rating for IMRX
9/15
06:47 am
imrx
Rating for IMRX
Medium
Report
Rating for IMRX